118 related articles for article (PubMed ID: 8495635)
1. Marked decrease in serum HDL cholesterol levels by combined probucol-pravastatin treatment in hypercholesterolemic NIDDM patients.
Ikeda T
Diabetes Care; 1993 May; 16(5):849-50. PubMed ID: 8495635
[No Abstract] [Full Text] [Related]
2. Effects of cholesterol-lowering treatments on oxidative modification of plasma intermediate density lipoprotein plus low density lipoprotein fraction in Type 2 diabetic patients.
Harada N; Kashiwagi A; Nishio Y; Kikkawa R
Diabetes Res Clin Pract; 1999 Feb; 43(2):111-20. PubMed ID: 10221663
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.
Saku K; Zhang B; Hirata K; Okura Y; Bai H; Liu R; Arakawa K
Eur J Clin Pharmacol; 1993; 44(6):535-9. PubMed ID: 8405008
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and tolerability of pravastatin in hypercholesterolemia in patients with non-insulin-dependent diabetes mellitus. Hyogo Pravastatin Study Group.
Kazumi T; Yoshino G; Ishida Y; Iwatani I; Morita S; Tateiwa M; Kasuga M
Diabetes Res Clin Pract; 1995 Jan; 27(1):61-8. PubMed ID: 7781495
[TBL] [Abstract][Full Text] [Related]
5. Effect of pravastatin on serum lipids, apolipoproteins and lipoprotein (a) in patients with non-insulin dependent diabetes mellitus.
Umeda F; Watanabe J; Inoue K; Hisatomi A; Mimura K; Yamauchi T; Sako Y; Kunisaki M; Tajiri Y; Nawata H
Endocrinol Jpn; 1992 Feb; 39(1):45-50. PubMed ID: 1535040
[TBL] [Abstract][Full Text] [Related]
6. A multinational study of the effects of low-dose pravastatin in patients with non-insulin-dependent diabetes mellitus and hypercholesterolemia. Pravastatin Multinational Study Group for Diabetes.
Behounek BD; McGovern ME; Kassler-Taub KB; Markowitz JS; Bergman M
Clin Cardiol; 1994 Oct; 17(10):558-62. PubMed ID: 8001304
[TBL] [Abstract][Full Text] [Related]
7. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
[TBL] [Abstract][Full Text] [Related]
8. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
Nishimura R; Sone H; Nakagami T; Tajima N
Diabetes Res Clin Pract; 2013 May; 100(2):e31-3. PubMed ID: 23522341
[TBL] [Abstract][Full Text] [Related]
9. Effects of probucol and pravastatin on plasma lipids, activities of postheparin lipoprotein lipase, and lecithin cholesterol acyltransferase and apo A-I containing lipoproteins with and without apo A-II in patients with moderate hypercholesterolemia.
Kagami A; Ishikawa T; Tada N; Sakamoto T; Mochizuki K; Nagano M; Moriguchi EH; Manabe M
Clin Biochem; 1993 Apr; 26(2):101-7. PubMed ID: 8485855
[TBL] [Abstract][Full Text] [Related]
10. A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.
Davidson MH; Testolin LM; Maki KC; von Duvillard S; Drennan KB
Arch Intern Med; 1997 Jun; 157(11):1186-92. PubMed ID: 9183229
[TBL] [Abstract][Full Text] [Related]
11. Opposite effects on serum cholesteryl ester transfer protein levels between long-term treatments with pravastatin and probucol in patients with primary hypercholesterolemia and xanthoma.
Inazu A; Koizumi J; Kajinami K; Kiyohar T; Chichibu K; Mabuchi H
Atherosclerosis; 1999 Aug; 145(2):405-13. PubMed ID: 10488970
[TBL] [Abstract][Full Text] [Related]
12. Effect of probucol on hypercholesterolemia in renal transplant patients.
Okubo M; Nakamura M; Horii A; Kamata K; Takeuchi Y; Tsukamoto Y; Kobayashi N; Sato K; Endo T
Kidney Int Suppl; 1999 Jul; 71():S229-30. PubMed ID: 10412784
[TBL] [Abstract][Full Text] [Related]
13. [Pravastatin vs. probucol in the treatment of hypercholesterolemia. A double-blind study].
Sienra-Pérez JC; Lerman-Garber I; Ahumada-Ayala M; Castañón-Romo C; Cardoso-Saldaña G; Laguna-Castellanos M; Posadas-Romero C
Arch Inst Cardiol Mex; 1991; 61(4):365-73. PubMed ID: 1953212
[TBL] [Abstract][Full Text] [Related]
14. A controlled trial of pravastatin vs probucol in the treatment of primary hypercholesterolemia.
Gómez-Pérez FJ; Bustamante F; Vergara A; Villaseñor J; Wong B; Rull JA
Rev Invest Clin; 1992; 44(1):53-61. PubMed ID: 1523350
[TBL] [Abstract][Full Text] [Related]
15. Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.
Stender S; Schuster H; Barter P; Watkins C; Kallend D;
Diabetes Obes Metab; 2005 Jul; 7(4):430-8. PubMed ID: 15955130
[TBL] [Abstract][Full Text] [Related]
16. Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study.
Schuster H; Barter PJ; Stender S; Cheung RC; Bonnet J; Morrell JM; Watkins C; Kallend D; Raza A;
Am Heart J; 2004 Apr; 147(4):705-13. PubMed ID: 15077101
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hypercholesterolemia in NIDDM with policosanol.
Torres O; Agramonte AJ; Illnait J; Más Ferreiro R; Fernández L; Fernández JC
Diabetes Care; 1995 Mar; 18(3):393-7. PubMed ID: 7555484
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low-dose pravastatin in patients with mild hyperlipidemia associated with type II diabetes mellitus.
Krempf M; Berthezène F; Wemeau JL; Moinade S; Desriac I; Amelineau E; Passa P
Diabetes Metab; 1997 Apr; 23(2):131-6. PubMed ID: 9137901
[TBL] [Abstract][Full Text] [Related]
19. [Effects of lovastatin and probucol on lipoprotein fractions in patients with hypercholesterolemia. A Brazilian multicenter study].
Forti N; Ramires JA
Arq Bras Cardiol; 1991 Sep; 57(3):253-61. PubMed ID: 1824203
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of pravastatin once daily in primary moderate hypercholesterolemia: the Israeli experience.
Beigel Y; Brook G; Eisenberg S; Fainaru M; Harats D; Levy Y; Rubinstein A; Skurnik Y
Isr J Med Sci; 1993 May; 29(5):272-7. PubMed ID: 8314685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
